Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis.

Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis.

OBJECTIVE: To evaluate the efficacy, pharmacokinetics, immunogenicity, and safety of multiple infusions of a chimeric monoclonal anti-tumor necrosis factor alpha antibody (cA2) (infliximab; Remicade, Centocor, Malvern, PA) given alone or in combination with low-dose methotrexate (MTX) in rheumatoid...

Podrobná bibliografie
Hlavní autoři:	Maini, R, Breedveld, F, Kalden, JR, Smolen, J, Davis, D, Macfarlane, J, Antoni, C, Leeb, B, Elliott, M, Woody, J, Schaible, T, Feldmann, M
Médium:	Journal article
Jazyk:	English
Vydáno:	1998

Podobné jednotky

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis.
Autor: Elliott, M, a další
Vydáno: (1994)

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group.
Autor: Maini, R, a další
Vydáno: (1999)

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.
Autor: Lipsky, P, a další
Vydáno: (2000)

Infliximab and methotrexate in the treatment of rheumatoid arthritis
Autor: Lipsky, P, a další
Vydáno: (2000)

Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor alpha antibody in rheumatoid arthritis.
Autor: Paleolog, E, a další
Vydáno: (1996)

Anti-tumor necrosis factor-alpha therapy of rheumatoid arthritis.
Autor: Feldmann, M, a další
Vydáno: (1997)

Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis.
Autor: Elliott, M, a další
Vydáno: (1994)

Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis.
Autor: Charles, P, a další
Vydáno: (1999)

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.
Autor: Elliot, M, a další
Vydáno: (2008)

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.
Autor: Elliott, M, a další
Vydáno: (1993)

Updated consensus statement on tumour necrosis factor blocking agents for the treatment of rheumatoid arthritis (May 2000).
Autor: Furst, D, a další
Vydáno: (2000)

Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor alpha monoclonal antibody treatment in patients with rheumatoid arthritis.
Autor: Tak, P, a další
Vydáno: (1996)

Use of anti-tumor necrosis factor antibodies in rheumatoid arthritis.
Autor: Feldmann, M, a další
Vydáno: (1994)

Beneficial effects of tumour necrosis factor-alpha (TNF-alpha) blockade in rheumatoid arthritis (RA)
Autor: Maini, R, a další
Vydáno: (1995)

Olokizumab, a monoclonal antibody against interleukin-6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by tumour necrosis factor inhibitor therapy: efficacy and safety results of a randomised controlled phase III study
Autor: E. Feist, a další
Vydáno: (2023-04-01)

Immunological intervention reveals reciprocal roles for tumor necrosis factor-alpha and interleukin-10 in rheumatoid arthritis and systemic lupus erythematosus.
Autor: Maini, R, a další
Vydáno: (1994)

Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials.
Autor: Charles, P, a další
Vydáno: (2000)

Anaemia of chronic disease in rheumatoid arthritis: in vivo effects of tumour necrosis factor alpha blockade.
Autor: Davis, D, a další
Vydáno: (1997)

Intravitreal methotrexate infusion for proliferative vitreoretinopathy
Autor: Sadaka A, a další
Vydáno: (2016-09-01)

Similarities in the mechanisms of action of pulse corticosteroids and anti-tumor necrosis factor alpha therapy in rheumatoid arthritis - Reply
Autor: Maini, R, a další
Vydáno: (1998)

Olokizumab plus methotrexate: safety and efficacy over 106 weeks of treatment
Autor: Eugen Feist, a další
Vydáno: (2024-12-01)

Life-Threatening Gastrointestinal Mucosal Necrosis during Methotrexate Treatment for Rheumatoid Arthritis
Autor: Tomoya Tsukada, a další
Vydáno: (2013-11-01)

Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed
Autor: Feldmann, M, a další
Vydáno: (2020)

Selective immunosuppression of tumour necrosis factor-alpha in rheumatoid arthritis.
Autor: Brennan, F, a další
Vydáno: (1995)

Monoclonal anti-TNF alpha antibody as a probe of pathogenesis and therapy of rheumatoid disease.
Autor: Maini, R, a další
Vydáno: (1995)

Anti-tumor necrosis factor alpha therapy of rheumatoid arthritis. Mechanism of action.
Autor: Feldmann, M, a další
Vydáno: (1997)

The transfer of a laboratory based hypothesis to a clinically useful therapy: the development of anti-TNF therapy of rheumatoid arthritis.
Autor: Feldmann, M, a další
Vydáno: (2004)

Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis.
Autor: Chu, C, a další
Vydáno: (1991)

Epinephrine infusion as an adjuvant treatment for breakthrough reactions during desensitization to methotrexate
Autor: Carla Toledo-Salinas, MD, a další
Vydáno: (2024-10-01)

Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis.
Autor: Taylor, P, a další
Vydáno: (2000)

Changes in serum lipids in patients with rheumatoid arthritis treated with a combination of tocilizumab and methotrexate compared with methotrexate alone for 24 weeks of observation
Autor: E. V. Udachkina, a další
Vydáno: (2015-11-01)

Changes in serum lipids in patients with rheumatoid arthritis treated with a combination of tocilizumab and methotrexate compared with methotrexate alone for 24 weeks of observation
Autor: E. V. Udachkina, a další
Vydáno: (2015-11-01)

Side Effects of Methotrexate and Tumor Necrosis Factor Inhibitors: Differences in Tolerability Among Patients With Psoriatic Arthritis and Rheumatoid Arthritis
Autor: Alexis Ogdie, a další
Vydáno: (2022-11-01)

Continuous fluid infusion per rectum compared with intravenous fluid infusion in pigs
Autor: Munashe Chigerwe, a další
Vydáno: (2023-07-01)

Localization of tumor necrosis factor receptors in the synovial tissue and cartilage-pannus junction in patients with rheumatoid arthritis. Implications for local actions of tumor necrosis factor alpha.
Autor: Deleuran, B, a další
Vydáno: (1992)

Effectiveness and safety of intravenous golimumab with and without concomitant methotrexate in patients with rheumatoid arthritis in the prospective, noninterventional AWARE study
Autor: Aaron Broadwell, a další
Vydáno: (2023-03-01)

INCREASED EXPRESSION OF TUMOR-NECROSIS-FACTOR RECEPTORS ON CELLS ISOLATED FROM RHEUMATOID-ARTHRITIS SYNOVIAL JOINTS
Autor: Gibbons, D, a další
Vydáno: (1992)

A 16-week multicenter observational study of the efficiency and safety of rheumatoid arthritis therapy with methotrexate
Autor: R. M. Balabanova
Vydáno: (2018-12-01)

Intravenous drugs infusion safety through smart pumps
Autor: C. Gómez-Baraza, a další
Vydáno: (2014-07-01)

Smart Intravenous Infusion Dosing System
Autor: Dragana Oros, a další
Vydáno: (2021-01-01)